Precision Biosciences (DTIL) Operating Income (2018 - 2025)
Historic Operating Income for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to -$20.7 million.
- Precision Biosciences' Operating Income rose 285.78% to -$20.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$89.5 million, marking a year-over-year decrease of 45227.69%. This contributed to the annual value of -$26.2 million for FY2024, which is 4018.2% up from last year.
- Per Precision Biosciences' latest filing, its Operating Income stood at -$20.7 million for Q3 2025, which was up 285.78% from -$21.9 million recorded in Q2 2025.
- In the past 5 years, Precision Biosciences' Operating Income registered a high of $24.1 million during Q2 2024, and its lowest value of -$30.7 million during Q4 2021.
- Over the past 5 years, Precision Biosciences' median Operating Income value was -$14.9 million (recorded in 2023), while the average stood at -$13.6 million.
- Per our database at Business Quant, Precision Biosciences' Operating Income skyrocketed by 87168.42% in 2024 and then crashed by 42811.08% in 2025.
- Precision Biosciences' Operating Income (Quarter) stood at -$30.7 million in 2021, then surged by 60.59% to -$12.1 million in 2022, then decreased by 22.97% to -$14.9 million in 2023, then tumbled by 66.86% to -$24.8 million in 2024, then increased by 16.82% to -$20.7 million in 2025.
- Its Operating Income stands at -$20.7 million for Q3 2025, versus -$21.9 million for Q2 2025 and -$22.1 million for Q1 2025.